Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Cutaneous Lichen Planus [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the efficacy and safety of ruxolitinib cream for cutaneous lichen planus has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lichen Planus

Drugs mentioned

• Ruxolitinib Cream (ruxolitinib)

Snippet

Sponsor: Incyte Corporation | Conditions: Cutaneous Lichen Planus | Phase 2 | Status: COMPLETED | Results posted: 2024-10-24